Detraining-related changes in left ventricular wall thickness and longitudinal strain in a young athlete likely to

Cesare de Gregorio1, Giampiero Speranza, Alberto Magliarditi

  • 1Clinical and Experimental Department of Medicine and Pharmacology, University Hospital of Messina , Messina, Italy.

Insights

Detraining can reverse left ventricular hypertrophy (LVH) in young athletes, even those with hypertrophic cardiomyopathy. This finding helps differentiate physiological LVH from pathological conditions in athletes.

Area of Science:

  • Cardiology
  • Sports Medicine
  • Medical Diagnostics

Background:

  • Differentiating physiological left ventricular hypertrophy (LVH) from pathological conditions like hypertrophic cardiomyopathy (HCM) in athletes is crucial.
  • Wall thickness reduction after detraining is a recognized marker for physiological LVH (athlete's heart).
  • Physical training can trigger the clinical presentation of HCM in adolescent athletes.

Purpose of the Study:

  • To describe detraining-related regression of LVH and improved myocardial deformation in a junior athlete with suspected hypertrophic cardiomyopathy.
  • To investigate the potential for reverse remodeling in adolescent athletes diagnosed with HCM.

Main Methods:

  • Case report detailing a junior athlete's response to a 3-month detraining period.
  • Utilized 12-lead ECG for initial diagnosis and echocardiography to assess LVH regression and myocardial deformation.

Main Results:

  • The athlete exhibited significant reduction in left ventricular wall thickness after detraining, indicating reverse remodeling.
  • Improvement in myocardial deformation was observed alongside the regression of LVH.
  • These findings challenge the assumption that reverse remodeling is exclusive to physiological LVH.

Conclusions:

  • Reverse left ventricular remodeling (wall thickness reduction) can occur in adolescent athletes with hypertrophic cardiomyopathy following a detraining period.
  • This observation highlights the importance of considering detraining effects when diagnosing LVH in young athletes.
  • Echocardiographic assessment during detraining may aid in differentiating HCM from physiological LVH.

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
812
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
2.3K
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
802
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
762
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
1.3K